<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04552210</url>
  </required_header>
  <id_info>
    <org_study_id>Mannose</org_study_id>
    <nct_id>NCT04552210</nct_id>
  </id_info>
  <brief_title>Mannose Binding Lectin Gene Polymorphism Versus Microbial Virulence in the Pathogenesis of Vulvovaginal Candidiasis</brief_title>
  <official_title>Mannose Binding Lectin Gene Polymorphism Versus Microbial Virulence in the Pathogenesis of Vulvovaginal Candidiasis in Egypt</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aljazeera Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aljazeera Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The vaginal mucosa is inhabited by both fungal and bacterial microorganisms which normally&#xD;
      co-exist with the host in a tightly regulated and commensal manner.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Nevertheless, under certain circumstances, this co-existence can turn into a pathologic state&#xD;
      followed by symptomatic disease&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 16, 2020</start_date>
  <completion_date type="Anticipated">February 20, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 15, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>the number of women who have mutation in MBL2 gene polymorphism</measure>
    <time_frame>a month</time_frame>
    <description>women who have mutation in MBL2 gene polymorphism</description>
  </primary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Infection</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>blood sample</intervention_name>
    <description>Whole blood was collected on EDTA (1mg/ml) to prevent clotting and DNA degradation.</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Detection of MBL2 single nucleotide polymorphisms (SNPs):&#xD;
&#xD;
      The three SNPs in the promoter regions; rs11003125 (L/H), rs7096206 (Y/X), rs7095891 (P/Q),&#xD;
      and one SNP rs1800450 (Gly54Asp) present in codon 54 of MBL2 were genotyped using ARMS-PCR&#xD;
      (amplification refractory mutation system- PCR)&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Married females in the reproductive age period. 2. Females complaining of vaginal discharge&#xD;
        (whitish and scanty), itching, dyspareunia, pruritis, and signs of vulvovaginitis ie.&#xD;
        erythema.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  1. Married females in the reproductive age period. 2. Females complaining of vaginal&#xD;
             discharge (whitish and scanty), itching, dyspareunia, pruritis, and signs of&#xD;
             vulvovaginitis ie. erythema.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  females who attended the same clinic in the same period, matched the cases regarding&#xD;
             the age group, without having Candida infection as confirmed by culture of vaginal&#xD;
             swabs.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>female with candidal infection</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>42 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Mahmoud Alalfy</last_name>
    <role>Study Chair</role>
    <affiliation>Algezeera hospitaland National Research Centre ,Egypt</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mahmoud Alalfy</last_name>
    <phone>01002611058</phone>
    <email>mahmoudalalfy@ymail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ahmed Elgazzar</last_name>
    <phone>01014005959</phone>
    <email>elgazzara50@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Algazeerah</name>
      <address>
        <city>Giza</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mahmoud Alalfy, master</last_name>
      <phone>+201002611058</phone>
      <email>mahmoudalalfy@ymail.com</email>
    </contact>
    <contact_backup>
      <last_name>Ahmed Elgazzar, M.D</last_name>
      <phone>+201014005959</phone>
    </contact_backup>
    <investigator>
      <last_name>Mahmoud Alalfy, master</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>September 11, 2020</study_first_submitted>
  <study_first_submitted_qc>September 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 17, 2020</study_first_posted>
  <last_update_submitted>November 7, 2020</last_update_submitted>
  <last_update_submitted_qc>November 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Candidiasis</mesh_term>
    <mesh_term>Candidiasis, Vulvovaginal</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

